Evidence for a Physiological Role of Angiotensin-(1-7) in the Control of Hydroelectrolyte Balance
- 1 April 1996
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 27 (4) , 875-884
- https://doi.org/10.1161/01.hyp.27.4.875
Abstract
In this study we evaluated the possibility that angiotensin-(1-7) [Ang-(1-7)] acts as an endogenous osmoregulatory peptide by determining the effect of acute administration of its selective antagonist [D-Ala7]Ang-(1-7) (A-779) on renal function parameters in rats. In addition, we investigated the physiological mechanisms involved in the antidiuretic effect of Ang-(1-7). The antidiuretic effect of Ang-(1-7) (40 pmol/0.05 mL per 100 g BW) in water-loaded rats was completely blocked by A-779 (vehicle-treated, 3.34 +/- 0.43 mL/h; Ang-(1-7), 1.48 +/- 0.23; A-779, 2.72 +/- 0.35; Ang-(1-7) plus A-779, 3.26 +/- 0.49). In contrast, the antidiuretic effect of Ang-(1-7) was not significantly changed by a vasopressin V2 receptor antagonist in a dose that completely blocked the antidiuresis produced by an equipotent dose of vasopressin. In addition, Ang-(1-7) administration did not significantly change vasopressin plasma levels in water-loaded rats. The antidiuretic effect of Ang-(1-7) in water-loaded rats was associated with a reduction of creatinine clearance (0.68 +/- 0.04 versus 1.38 +/- 0.32 mL/min in vehicle-treated rats, P <.05) and an increase in urine osmolality (266.8 +/- 32.7 versus 182.8 +/- 14 mOsm/kg in vehicle-treated rats, P <.05). An effect of Ang-(1-7) in tubular water transport was demonstrated in vitro by a fourfold increase in the hydraulic conductivity of inner medullary collecting ducts in the presence of 1 nmol/L Ang-(1-7). Subcutaneous administration of A-779 (2.3 to 9.2 nmol/100 g) produced a significant increase in urine volume (4.6 nmol/100 g, 0.45 +/- 0.12 mL/h; vehicle-treated rats, 0.16 +/- 0.03 mL/h; P <.05) comparable to that of acute administration of a vasopressin V2 receptor antagonist. The diuretic effect of A-779 was associated with an increase in creatinine clearance and decrease in urine osmolality. In contrast, no significant effects on urine volume were observed after systemic administration of angiotensin subtype 1 or 2 receptor antagonists (DuP 753 and CGP 42112A, respectively). These findings suggest that endogenous Ang-(1-7), acting on specific receptors, participates in the control of hydroelectrolyte balance by influencing especially water excretion.Keywords
This publication has 34 references indexed in Scilit:
- Evidence that angiotensin-(1–7) plays a role in the central control of blood pressure at the ventro-lateral medulla acting through specific receptorsBrain Research, 1994
- Plasma angiotensin(1–7) immunoreactivity is increased by salt load, water deprivation, and hemorrhagePeptides, 1994
- Cardiovascular effects produced by micro-injection of angiotensin-(1–7) on vasopressor and vasodepressor sites of the ventrolateral medullaBrain Research, 1993
- Production of angiotensin-(1-7) by human vascular endothelium.Hypertension, 1992
- Neurophysiological responses to angiotensin-(1-7).Hypertension, 1991
- Pathways of angiotensin formation and function in the brain.Hypertension, 1990
- Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 1989
- Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide.Proceedings of the National Academy of Sciences, 1988
- Large conduit arteries in hypertension: role of the vascular renin-angiotensin system.Circulation, 1988
- Crossover design to test antihypertensive drugs with self-recorded blood pressure.Hypertension, 1988